Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromyalgi

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromyalgi

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pierre fabre dermatologie - fluoruracil - creme - 40 mg/g

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - binimetinib - melanom - antineoplastiske midler - binimetinib i kombination med encorafenib er indiceret til behandling af voksne patienter med inoperabel eller metastatisk melanom med en braf v600 mutation.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - neratinib - bryst neoplasmer - antineoplastiske midler - nerlynx er indiceret til forlænget adjuverende behandling af voksne patienter med tidlige fase hormon receptor positiv her2-overexpressed/forstærket brystkræft, og som er mindre end ét år fra afslutningen af forudgående adjuvans trastuzumab baseret terapi.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pierre fabre medicament - nicotineresinat - sugetabletter - 2,5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pierre fabre medicament - nicotineresinat - sugetabletter - 2,5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pierre fabre pharma norden ab - vinorelbintartrat - kapsler, bløde - 30 mg